«Hairy Cell Leukemia

Below is an extended Hairy Cell Leukemia patents listing. Click here to return to the Hairy Cell Leukemia main in depth entry.

Patents :
US Patent No.	Title
7393949	Human immunodeficiency virus (HIV) nucleotide sequences
7402656	PRO10013 polypeptides
7402661	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7405041	Methods for regulating transcription by targeting quadruplex DNA
7405226	Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
7405227	Treatment of cancer
7405233	Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
7405268	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7405269	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7405295	Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
7405317	Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
7402579	Quinobenzoxazine analogs and compositions
7402305	Polypeptides of the IFN.alpha.-21 gene
7399834	Anti-PRO1558 antibodies
7393954	Process for the production of pentostatin aglycone and pentostatin
7396662	C-type lectin polypeptides
7396906	Pro4399 Polypeptides
7396907	Antibodies that bind PRO6182 polypeptides
7396916	Antibody to a polypeptide overexpressed in tumors
7399464	Polypeptides of the IFN.alpha.-7 gene
7399613	Sialic acid nucleotide sugars
7399824	PRO19680 antibodies
7399828	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7399829	Variants of RANKL protein
7407973	Use of pirfenidone in therapeutic regimens
7407985	Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
7411051	Antibodies to HDPPA04 polypeptide
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7413737	Anti-hydroxylase antibodies and uses thereof
7414050	Inhibitors of c-fms kinase
7414055	Inhibitors of Akt activity
7414063	Inhibitors of Akt (protein kinase B)
7414076	Methods and compositions for treating amyloid-related diseases
7417115	PRO6027 polypeptides
7417116	PRO7155 polypeptides
7417123	PRO4399 Antibodies
7411047	PRO6097 antibodies
7411040	PRO6182 polypeptides
7411037	Polypeptides encoded by a nucleic acid underexpressed in melanoma
7408032	PRO1188 polypeptides
7408033	PRO5995 polypeptides
7408034	PRO20025 polypeptides
7408035	PRO9864 polypeptides
7408038	Secreted immunomodulatory proteins
7408041	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
7408042	Anti-PRO6181 antibodies
7408053	Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby
7410772	Compositions and methods for treatment of non-Hodgkin's lymphoma
7410988	2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
7417125	Antibodies that bind a PRO1158 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.